pCMV4a-Flag-c-Myc Citations (3)

Originally described in: A SIRT2-Selective Inhibitor Promotes c-Myc Oncoprotein Degradation and Exhibits Broad Anticancer Activity.
Jing H, Hu J, He B, Negron Abril YL, Stupinski J, Weiser K, Carbonaro M, Chiang YL, Southard T, Giannakakou P, Weiss RS, Lin H Cancer Cell. 2016 Mar 14;29(3):297-310. doi: 10.1016/j.ccell.2016.02.007. PubMed Journal

---

Articles Citing pCMV4a-Flag-c-Myc

Articles
Inhibition of the erythropoietin-producing receptor EPHB4 antagonizes androgen receptor overexpression and reduces enzalutamide resistance. Li C, Lanman NA, Kong Y, He D, Mao F, Farah E, Zhang Y, Liu J, Wang C, Wei Q, Liu X. J Biol Chem. 2020 Apr 17;295(16):5470-5483. doi: 10.1074/jbc.RA119.011385. Epub 2020 Mar 17. PubMed
In oxygen-deprived tumor cells ERp57 provides radioprotection and ensures proliferation via c-Myc, PLK1 and the AKT pathway. Ocklenburg T, Neumann F, Wolf A, Vogel J, Gopelt K, Baumann M, Baumann J, Kranz P, Metzen E, Brockmeier U. Sci Rep. 2021 Mar 30;11(1):7199. doi: 10.1038/s41598-021-86658-5. PubMed
Targeted recruitment of USP15 enhances CTLA4 surface levels and restricts its degradation. Querques F, Ciampani V, Tey PY, Kutilek VD, Kadic E, Clague MJ, Urbe S. Life Sci Alliance. 2026 Jan 22;9(4):e202503563. doi: 10.26508/lsa.202503563. Print 2026 Apr. PubMed

If you have published an article using this material, please email us at to have your article added to this page.